155 related articles for article (PubMed ID: 24982394)
1. Metastatic spinal cord compression from pancreatic cancer.
Rades D; Huttenlocher S; Schild SE; Bartscht T
Anticancer Res; 2014 Jul; 34(7):3727-30. PubMed ID: 24982394
[TBL] [Abstract][Full Text] [Related]
2. Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary.
Rades D; Fehlauer F; Veninga T; Stalpers LJ; Basic H; Hoskin PJ; Rudat V; Karstens JH; Schild SE; Dunst J
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):532-7. PubMed ID: 17084539
[TBL] [Abstract][Full Text] [Related]
3. Motor function and survival following radiotherapy alone for metastatic epidural spinal cord compression in melanoma patients.
Huttenlocher S; Sehmisch L; Rudat V; Rades D
J Dermatol; 2014 Dec; 41(12):1082-6. PubMed ID: 25327333
[TBL] [Abstract][Full Text] [Related]
4. Single-Fraction Versus 5-Fraction Radiation Therapy for Metastatic Epidural Spinal Cord Compression in Patients With Limited Survival Prognoses: Results of a Matched-Pair Analysis.
Rades D; Huttenlocher S; Šegedin B; Perpar A; Conde AJ; Garcia R; Veninga T; Stalpers LJ; Cacicedo J; Rudat V; Schild SE
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):368-72. PubMed ID: 26232852
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression.
Rades D; Stalpers LJ; Veninga T; Schulte R; Hoskin PJ; Obralic N; Bajrovic A; Rudat V; Schwarz R; Hulshof MC; Poortmans P; Schild SE
J Clin Oncol; 2005 May; 23(15):3366-75. PubMed ID: 15908648
[TBL] [Abstract][Full Text] [Related]
6. A comparison of two different radiation schedules for metastatic spinal cord compression considering a new prognostic factor.
Rades D; Karstens JH
Strahlenther Onkol; 2002 Oct; 178(10):556-61. PubMed ID: 12386787
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer.
Rades D; Stalpers LJ; Veninga T; Rudat V; Schulte R; Hoskin PJ
J Urol; 2006 Feb; 175(2):552-6. PubMed ID: 16406994
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors predicting functional outcomes, recurrence-free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients.
Rades D; Veninga T; Stalpers LJ; Schulte R; Hoskin PJ; Poortmans P; Schild SE; Rudat V
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):182-8. PubMed ID: 16198069
[TBL] [Abstract][Full Text] [Related]
9. Escalation of radiation dose beyond 30 Gy in 10 fractions for metastatic spinal cord compression.
Rades D; Karstens JH; Hoskin PJ; Rudat V; Veninga T; Schild SE; Dunst J
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):525-31. PubMed ID: 17141977
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for functional outcome and survival after reirradiation for in-field recurrences of metastatic spinal cord compression.
Rades D; Rudat V; Veninga T; Stalpers LJ; Hoskin PJ; Schild SE
Cancer; 2008 Sep; 113(5):1090-6. PubMed ID: 18642349
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression.
Rades D; Fehlauer F; Schulte R; Veninga T; Stalpers LJ; Basic H; Bajrovic A; Hoskin PJ; Tribius S; Wildfang I; Rudat V; Engenhart-Cabilic R; Karstens JH; Alberti W; Dunst J; Schild SE
J Clin Oncol; 2006 Jul; 24(21):3388-93. PubMed ID: 16849752
[TBL] [Abstract][Full Text] [Related]
12. Survival in patients with metastatic spinal cord compression from prostate cancer is associated with the number of extra-spinal organs involved.
Weber A; Bartscht T; Karstens JH; Schild SE; Rades D
Anticancer Res; 2013 Oct; 33(10):4505-7. PubMed ID: 24123022
[TBL] [Abstract][Full Text] [Related]
13. Do bladder cancer patients with metastatic spinal cord compression benefit from radiotherapy alone?
Rades D; Walz J; Schild SE; Veninga T; Dunst J
Urology; 2007 Jun; 69(6):1081-5. PubMed ID: 17572191
[TBL] [Abstract][Full Text] [Related]
14. A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study.
Rades D; Fehlauer F; Stalpers LJ; Wildfang I; Zschenker O; Schild SE; Schmoll HJ; Karstens JH; Alberti W
Cancer; 2004 Dec; 101(11):2687-92. PubMed ID: 15493037
[TBL] [Abstract][Full Text] [Related]
15. Outcomes After Irradiation of Epidural Spinal Cord Compression Due to Metastatic Thyroid Cancer.
Rades D; Janssen S; Käsmann L; Bolm L; Schild SE
Anticancer Res; 2016 Apr; 36(4):2035-9. PubMed ID: 27069199
[TBL] [Abstract][Full Text] [Related]
16. 1x8 Gy versus 5x4 Gy for metastatic epidural spinal cord compression: a matched-pair study of three prognostic patient subgroups.
Rades D; Conde-Moreno AJ; Cacicedo J; Veninga T; Segedin B; Stanic K; Rudat V; Schild SE
Radiat Oncol; 2018 Feb; 13(1):21. PubMed ID: 29422106
[TBL] [Abstract][Full Text] [Related]
17. Predicting survival of patients with metastatic epidural spinal cord compression from cancer of the head-and-neck.
Rades D; Schild SE; Karstens JH; Hakim SG
Anticancer Res; 2015 Jan; 35(1):385-8. PubMed ID: 25550576
[TBL] [Abstract][Full Text] [Related]
18. A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses.
Rades D; Huttenlocher S; Veninga T; Bajrovic A; Bremer M; Rudat V; Schild SE
Radiat Oncol; 2015 Apr; 10():90. PubMed ID: 25889036
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 1 x 8 Gy and 10 x 3 Gy for functional outcome in patients with metastatic spinal cord compression.
Rades D; Stalpers LJ; Hulshof MC; Borgmann K; Karstens JH; Koning CC; Alberti W
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):514-8. PubMed ID: 15890595
[TBL] [Abstract][Full Text] [Related]
20. Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases.
Rades D; Veninga T; Stalpers LJ; Basic H; Rudat V; Karstens JH; Dunst J; Schild SE
J Clin Oncol; 2007 Jan; 25(1):50-6. PubMed ID: 17194905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
